Chr Hansen ingredients unit up for sale

- Last updated on GMT

Related tags: Chr hansen, Stock

Number one cultures supplier Chr. Hansen is up for sale as its
major stakeholder decides to pull away from the ingredients slice
of the company to focus on the pharmaceutical unit. The move will
make the company's still growing cultures division in China a prime
target for speculators.

The move has evolved out of discussions over the past three years to separate the Danish group into two independent listed companies, an ingredient and an allergy vaccine company.

But the primary shareholder in Chr Hansen, the Lundbeck Foundation that has its roots in the pharmaceutical business, has since informed the group's board that it does not wish to be a long-term strategic shareholder in the ingredients company.

As such, the board of directors at Chr Hansen said they have "entered into an agreement with the investment banker Carnegie Bank to investigate the possibilities for a divestment of the ingredients sector"​.

The ingredients operations of Chr. Hansen include cultures, enzymes, colours - where it is the number one natural colour supplier - flavours, seasonings and sweeteners. Industry players with the clout to acquire Chr Hansen may well meet with competition concerns. As such, observers could suspect the group will be broken up into units.

In recent years, increasing competition in the saturated western market has meant struggle for the company's operation there. On the contrary, a strong performance from its operations in Asia Pacific, have been particularly buoyed by the major success of its cultures division in China, which has expanded exponentially, in line with the growth of the dairy industry there.

But the CEO of Chr Hansen, Erik Soerensen said that this is definitely not the case: "The ingredients business will not be split up, it is all or nothing."

Providing opportunities for cash rich, ambitious firms, either within or external to the food industry, the roll call of ingredients players on the market keeps on growing, largely against the backdrop of increasing consolidation in the food industry.

The retailers are extending their reach across the globe, and ingredients suppliers are under severe pressure - notably through squeezed margins - to keep up with the pace and to deliver products at competitive prices. Consolidation and economies of scale are one of the only routes open to them.

Last week the ingredients unit at Chr Hansen announced an 8 per cent increase in revenue for the year to DKK 3.4 billion, up from DKK3.34 billion on the previous year. The ALK-Abello allergy unit pulled in sales of DKK 1.05 billion, a rise from DKK 991 on the previous year.

The market welcomed the news of the divestment this morning with Chr Hansen's share price on the Copenhagen stock exchange spiking more than 13 per cent to DKK645 at 11.22am today.

Related topics: Ingredients

Related products

show more

Subtleties in sugar reduction

Subtleties in sugar reduction

Cargill | 25-Oct-2022 | Technical / White Paper

While indulgence became common practice during the stress of a global pandemic, consumer habits are returning to normalcy… spurred on by new research on...

Functional Forecasting

Functional Forecasting

Kerry | 18-Oct-2022 | Insight Guide

In a market worth $240 billion globally, it’s crucial to develop functional beverages and supplements that will meet your customers’ needs for everyday...

Power up the next energy drink solution.

Power up the next energy drink solution.

ADM | 18-Oct-2022 | Infographic

Energy drink consumers are always on the lookout for better ways to power their day. Whether that’s innovative formulations suited for active situations,...

Accelerate alcoholic beverage innovation.

Accelerate alcoholic beverage innovation.

ADM | 06-Oct-2022 | Insight Guide

Products that contain real and authentic ingredients that support the perceived pureness found in nature are top of mind for modern consumers when choosing...

Follow us

Products

View more

Webinars